Published Date: 29 Sep 2026
Hoang discussed the CARD initiative started at Wayne State University in Detroit that she presented at the ACP IM 2025 meeting.
Read Full NewsPhase 2 VALIANT data show the anti-TSLP receptor antibody sharply reduced exacerbations in patients with high eosinophil counts.
Guy Brusselle, MD, PhD, explains why broader cytokine blockade with dupilumab outpaced omalizumab, and why nonremitters in EVEREST still improved.
Exploratory extracellular vesicle biomarkers suggested KP405, a brain-penetrant GLP-1/GIP agonist, engaged insulin signaling and neuroinflammation pathways in a small phase 1 study.
Late-breaking findings from MDS 2026 suggest a gluten-free diet may affect cognitive and quality-of-life measures in Parkinson disease, although no significant changes in motor function were observed.
Seven investigational cerebral palsy therapies—from baby-tooth stem cells to cannabinoids and botulinum toxin—show mixed early results, highlighting key clinical trial milestones ahead.
Benjamin Walter, MD, MBA, discusses how advances in biomarker testing and genetic characterization are informing Parkinson disease care, alongside developments in adaptive deep brain stimulation and efforts to identify disease earlier.
At a NeurologyLive Clinical Forum in Philadelphia, Jessica D. Schulte, MD, PhD, of NYU Grossman School of Medicine, discussed how earlier recognition and systemic therapy options are changing the treatment paradigm for patients with NF1-associated plexiform neurofibromas.
1.
MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy
2.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
3.
Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?
4.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
5.
Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis
1.
Circulating Tumor DNA Dynamics for Therapy Matching: A Comprehensive Clinical Review
2.
Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data
5.
Iron Homeostasis Throughout the Female Lifespan
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Navigating the Complexities of Ph Negative ALL - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation